Teva Launches A Generic Version of Dutasteride (Avodart)

Teva Pharmaceutical Industries has received approval and launched, in the United States, a generic version of the Avodart (dutasteride) capsules at the 0.5 mg dose. Avodart, 5-alpha reductase inhibitor, is FDA approved for the treatment of men with benign prostate hyperplasia (an enlarged prostate gland), however, although not approved; men often use it as a part of their hormone therapy treatment protocol (ADT). The use of Avodart as an ADT drug is controversial with more support from doctors on the west coast than on the east coast. The best-known exception to this is Dr. S. Meyers (east coast) who has [...]